EphA2 Polyclonal Antibody

EPHA2 belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands. Mutations in this gene are the cause of certain genetically-related cataract disorders.

The EphA2 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of EphA2 protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and specificity towards EphA2.

The EphA2 Polyclonal Antibody has been extensively validated for its performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits exceptional sensitivity and minimal background noise, enabling accurate and reliable results.

This antibody is suitable for use in both research and clinical settings, allowing for the investigation of EphA2 protein expression in normal and diseased tissues. Its versatility and robustness make it an indispensable tool for studying the role of EphA2 in various physiological and pathological processes.

The EphA2 Polyclonal Antibody is supplied in a convenient and ready-to-use format, ensuring ease of use and saving valuable time in the laboratory. It is available in different sizes to accommodate various experimental needs.

With its exceptional performance and reliability, the EphA2 Polyclonal Antibody is an essential tool for researchers and clinicians alike, facilitating the understanding of EphA2 biology and its potential as a therapeutic target.